Aquaculture Vaccines Market

Global Aquaculture Vaccines Market Report Description:

Global aquaculture vaccines market report gives comprehensive outlook on aquaculture vaccines across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global aquaculture vaccines market gives historical, current, and future market sizes (US$ Mn) on the basis of vaccine type, application, route of administration, species, and region. This report studies global aquaculture vaccines market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global aquaculture vaccines market report includes aquaculture production and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global aquaculture vaccines market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global aquaculture vaccines market report include suppliers, manufacturers, marketers, policy makers, and aquaculture service providers engaged in global aquaculture vaccines products usage and advocacy.

Global Aquaculture Vaccines Market:

The global aquaculture vaccines market estimated to be valued US$ XX Mn in 2017 and poised to grow at significant CAGR over 2018-2025 due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers.

Surge in the Prevalence of Aquaculture Diseases

Increase in the fish mortality due to certain disease outbreaks driving the growth of aquaculture vaccines market. For instance, in October 2017, approximately 125,000 salmon have died due to a disease outbreak at two fish farms on the Isle of Lewis due to bacterium Pasturella Skyensis infection. In addition, surge in population demand for the healthy fish products, demand for animal protein, government support for the aquaculture immunization programs, rise in adoption of aquaculture vaccines in the developed and developing nations are boost the aquaculture vaccines market over the forecast years. Moreover, increase in the international trading of aquaculture species immense boost the global aquaculture vaccines over the forecast period

Development and launch of newer aquaculture vaccines for different species

Development and launch of innovative vaccines to treat various infectious diseases in aquaculture species boosting the revenue growth of the global aquaculture vaccines market. For instance, In March 2018, Hipra launched Icthiovac VR/PD injectable vaccine for seabass against Vibriosis and Pasteurellosis in Greece. Apart from aforementioned dynamics, Raise in funding for the research and development of innovative aquaculture vaccines boost the market over forecast years. For instance, In March 2015, The Scottish Aquaculture Innovation Center (SAIC) has announced it is issuing grants worth almost GBP 950,000 to two major salmon farming research projects proposed by leading farmed salmon companies on sea lice and salmon vaccinations

Europe Accounts for Larger Market Revenue Share in Global Aquaculture Vaccines Market

Europe accounted for larger revenue share through 2013-2017 and the same trend is projected to follow over 2018-2025 owing to increase in the adoption of aquaculture vaccines in Norway, Russia, U.K, Greece, and other European countries coupled with increase in the aquaculture farming in the region are boost the market. Latin America market projected to exhibit significant growth owing launch of newer products into the Chile, Mexico, Brazil, and other Latin America countries is expected to enhance the market.

Competition Assessment

Key players profiled in the global aquaculture vaccines market include:

• Pharmaq AS (Zoetis, LLC) (Norway)
• Merck Animal Health (Merck & Co., Inc.) (USA)
• KoVax Ltd. (Part of Phibro Animal Health) (Israel)
• Hipra (Spain)
• Tecnovax SA (Argentina)
• Veterquimica S.A. (Chile)
• Nisseiken Co. Ltd. (Japan)
• Virbac S.A. (France)
• Elanco (USA)
• Kyoritsuseiyaku Corporation (Japan)

Global aquaculture vaccines market is surging owing to frequent product approvals and launchings by the market players. For instance, In June 2016, Norwegian fish health firm Pharmaq tested its live salmon rickettsial septicaemia (SRS) vaccine across 20 million young Chilean fish, after the innovative product was approved in February. Moreover, In January 2017, Pharmaq acquired fish vaccination company Nordland Sett Vaks to strengthen its fish vaccine portfolio.

Key Findings of the Report:

• Global Aquaculture Vaccines Market expanding at significant CAGR over 2018 to 2025 owing to increase in the adoption of aquaculture vaccines in developed and developing countries

• Based on product type inactivated aquaculture vaccines accounted for larger market revenue share in 2017 and projected gain market revenue share over the forecast period

• Players focusing on innovation of newer products and collaboration strategies to retain market position in global aquaculture vaccines market

Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2025)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

By Vaccine Type

• Inactivated Vaccine
• Attenuated Live Vaccine
• DNA Vaccine
• Others

By Application

• Bacterial Infection
• Viral Infection
• Combined Bacterial and Viral Infections
• Others

By Route of Administration

• Immersion Vaccines
• Injection Vaccines
• Oral Vaccines

By Species

• Salmon
• Seabass and Seabream
• Tilapia
• Trout
• Turbot
• Carp

Geography

• North America
  • USA
  • Canada
• Europe
  • Norway
  • Russia
  • United Kingdom
  • Greece
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Indonesia
  • Bangladesh
  • Philippines
  • Rest of Asia-Pacific
• Latin America
  • Chile
  • Brazil
  • Mexico
  • Peru
  • Rest of Latin America
• Middle East and Africa (MEA)
  • Egypt
  • Iran
  • Turkey
  • Uganda
  • Rest of MEA

1. Executive Summary
 
2. Global Aquaculture Vaccines Market Introduction
2.1. Global Aquaculture Vaccines Market – Taxonomy
2.2. Global Aquaculture Vaccines Market –Definitions
2.2.1. Type of Vaccine
2.2.2. Application
2.2.3. Species
2.2.4. Route of Administration
 
3. Global Aquaculture Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Aquaculture Vaccines Market Dynamics – Factors Impact Analysis
3.6. Global Aquaculture Vaccines Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Aquaculture Vaccines Market – Product Innovations
 
4. Global Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
 
5. Global Aquaculture Vaccines Market, By Product, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Inactivated vaccines
5.1.1. Inactivated virus or bacterial antigens
5.1.2. Sub-unit vaccines
5.1.3. Recombinant vaccines
5.2. Live vaccines
5.2.1. Attenuated live vaccines
5.2.2. Gene-deleted live vaccines
5.3. DNA vaccine
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
 
6. Global Aquaculture Vaccines Market Forecast, By Application, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Bacterial infections
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Viral infections
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Fungal infections
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Parasitic infections
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.4.3. Market Opportunity Analysis
 
7. Global Aquaculture Vaccines Market Forecast, By Species, 2013 – 2017 and Forecast, 2018 – 2024
7.1. Carps
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Carp
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Salmon
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Sea Bass
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.4.3. Market Opportunity Analysis
7.5. Sturgeon
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.5.3. Market Opportunity Analysis
7.6. Trout
7.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.6.3. Market Opportunity Analysis
7.7. Turbot
7.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.7.3. Market Opportunity Analysis
7.8. Sea bream
7.8.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.8.3. Market Opportunity Analysis
7.9. Others
7.9.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.9.3. Market Opportunity Analysis
 
8. Global Aquaculture Vaccines Market Forecast, By Route of Administration, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Immersion vaccination
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Injection vaccination
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Oral vaccination
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
8.4. Spray vaccination
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.4.3. Market Opportunity Analysis
 
9. Global Aquaculture Vaccines Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
9.1. North America
9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Aquaculture Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Region, 2018 – 2024
 
10. North America Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Inactivated vaccines
10.1.1.1. Inactivated virus or bacterial antigens
10.1.1.2. Sub-unit vaccines
10.1.1.3. Recombinant vaccines
10.1.2. Live vaccines
10.1.2.1. Attenuated live vaccines
10.1.2.2. Gene-deleted live vaccines
10.1.2.3. DNA vaccines
10.1.3. Others
10.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Bacterial infections
10.2.2. Viral infections
10.2.3. Fungal infections
10.2.4. Parasitic infections
10.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Carp
10.3.2. Salmon
10.3.3. Seabass
10.3.4. Sturgeon
10.3.5. Trout
10.3.6. Turbot
10.3.7. Sea bream
10.3.8. Others
10.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. U.S.
10.4.2. Canada
10.5. North America Aquaculture Vaccines Market – Opportunity Analysis Index, By vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
10.6. North America Aquaculture Vaccines Market Dynamics – Trends
 
11. Europe Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Inactivated vaccines
11.1.1.1. Inactivated virus or bacterial antigens
11.1.1.2. Sub-unit vaccines
11.1.1.3. Recombinant vaccines
11.1.2. Live vaccines
11.1.2.1. Attenuated live vaccines
11.1.2.2. Gene-deleted live vaccines
11.1.2.3. DNA vaccines
11.1.3. Others
11.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Bacterial infections
11.2.2. Viral infections
11.2.3. Fungal infections
11.2.4. Parasitic infections
11.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Carp
11.3.2. Salmon
11.3.3. Seabass
11.3.4. Sturgeon
11.3.5. Trout
11.3.6. Turbot
11.3.7. Sea bream
11.3.8. Others
11.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Germany
11.4.2. UK
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Russia
11.4.7. Poland
11.4.8. Rest of Europe
11.5. Europe Aquaculture Vaccines Market – Opportunity Analysis Index, , By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
11.6. Europe Aquaculture Vaccines Market Dynamics – Trends
 
12. Asia-Pacific Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Inactivated vaccines
12.1.1.1. Inactivated virus or bacterial antigens
12.1.1.2. Sub-unit vaccines
12.1.1.3. Recombinant vaccines
12.1.2. Live vaccines
12.1.2.1. Attenuated live vaccines
12.1.2.2. Gene-deleted live vaccines
12.1.2.3. DNA vaccines
12.1.3. Others
12.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Bacterial infections
12.2.2. Viral infections
12.2.3. Fungal infections
12.2.4. Parasitic infections
12.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Carp
12.3.2. Salmon
12.3.3. Seabass
12.3.4. Sturgeon
12.3.5. Trout
12.3.6. Turbot
12.3.7. Sea bream
12.3.8. Others
12.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. ASEAN
12.4.5. Australia & New Zealand
12.4.6. Rest of Asia-Pacific
12.5. Asia-Pacific Aquaculture Vaccines Market – Opportunity Analysis Index, , By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
12.6. Europe Aquaculture Vaccines Market Dynamics – Trends
 
13. Latin America Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
13.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Inactivated vaccines
13.1.1.1. Inactivated virus or bacterial antigens
13.1.1.2. Sub-unit vaccines
13.1.1.3. Recombinant vaccines
13.1.2. Live vaccines
13.1.2.1. Attenuated live vaccines
13.1.2.2. Gene-deleted live vaccines
13.1.2.3. DNA vaccines
13.1.3. Others
13.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Bacterial infections
13.2.2. Viral infections
13.2.3. Fungal infections
13.2.4. Parasitic infections
13.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Carp
13.3.2. Salmon
13.3.3. Seabass
13.3.4. Sturgeon
13.3.5. Trout
13.3.6. Turbot
13.3.7. Sea bream
13.3.8. Others
13.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Venezuela
13.4.5. Rest of Latin America
13.5. Latin America Aquaculture Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
13.6. Latin America Aquaculture Vaccines Market Dynamics – Trends
 
14. Middle East and Africa Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
14.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Inactivated vaccines
14.1.1.1. Inactivated virus or bacterial antigens
14.1.1.2. Sub-unit vaccines
14.1.1.3. Recombinant vaccines
14.1.2. Live vaccines
14.1.2.1. Attenuated live vaccines
14.1.2.2. Gene-deleted live vaccines
14.1.2.3. DNA vaccines
14.1.3. Others
14.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Bacterial infections
14.2.2. Viral infections
14.2.3. Fungal infections
14.2.4. Parasitic infections
14.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Carp
14.3.2. Salmon
14.3.3. Seabass
14.3.4. Sturgeon
14.3.5. Trout
14.3.6. Turbot
14.3.7. Sea bream
14.3.8. Others
14.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Gulf Cooperation Council (GCC) Countries
14.4.2. Israel
14.4.3. South Africa
14.4.4. Rest of MEA
14.5. MEA Aquaculture Vaccines Market – Opportunity Analysis Index, , By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
14.6. MEA Aquaculture Vaccines Market Dynamics – Trends
 
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Zoetis (Pfizer Inc.) (U.S.)
15.2.2. Benchmark Holdings Plc. (U.K.)
15.2.3. Ridgeway Biologicals Ltd. (U.K.)
15.2.4. Virbac (France)
15.2.5. Vaccibody AS (Bio-Medisinsk Innovasjon AS) (Norway)
15.2.6. Merck & Co. Inc. (U.S.)
15.2.7. Bayer Animal Health (Germany)
 
16. Research Methodology
 
17. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

ASK AN ANALYST

Request Customisation